You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT JAMA
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 281 No. 22, June 9, 1999 TABLE OF CONTENTS
  JAMA
  •  Online Features
  Editorial
 This Article
 •Full text
 •PDF
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Citing articles on ISI (15)
 •Contact me when this article is cited
 Related Content
 •Related article
 •Similar articles in JAMA
 Topic Collections
 •Menopause
 •Oncology
 •Breast Cancer
 •Alert me on articles by topic

Hormone Replacement Therapy and Risk of Breast Cancer

Trudy L. Bush, PhD, MHS; Maura K. Whiteman

JAMA. 1999;281:2140-2141.

Since this article does not have an abstract, we have provided the first 150 words of the full text and any section headings.

Does estrogen replacement therapy (ERT) or hormone replacement therapy (HRT) increase the risk of breast cancer? This question is still being asked today, even though more than 5 decades of experience with this therapy and scores of epidemiological studies addressing the issue are available. This important question refuses to go away, despite a lack of direct evidence supporting a causal association. It is a question that remains timely because of societal concerns about breast cancer and the large numbers of women who currently use HRT. And, it is a question that continues to be addressed in the medical literature and lay media because of the commonly held belief that estrogens in some way must cause breast cancer.

Based on information in the article by Gapstur and colleagues1 in this issue of THE JOURNAL, one new answer to this old question is yes, . . . [Full Text of this Article]

Author Affiliations: Department of Epidemiology and Preventive Medicine, University of Maryland School of Medicine, Baltimore.


RELATED ARTICLE

Hormone Replacement Therapy and Risk of Breast Cancer With a Favorable Histology: Results of the Iowa Women's Health Study
Susan M. Gapstur, Monica Morrow, and Thomas A. Sellers
JAMA. 1999;281(22):2091-2097.
ABSTRACT | FULL TEXT  


THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Risk of Mortality by Histologic Type of Breast Cancer Among Women Aged 50 to 79 Years
Li et al.
Arch Intern Med 2003;163:2149-2153.
ABSTRACT | FULL TEXT  

The Role of Hormone Replacement Therapy in the Prevention of Postmenopausal Heart Disease
Mosca
Arch Intern Med 2000;160:2263-2272.
ABSTRACT | FULL TEXT  

HRT and Breast Cancer: Good News, Bad News
JWatch Women's Health 1999;1999:12-12.
FULL TEXT  

Does Hormone Therapy Really Increase Risk for Breast Cancer?
JWatch General 1999;1999:2-2.
FULL TEXT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1999 American Medical Association. All Rights Reserved.